Less lenalidomide may be more in frail elderly multiple myeloma patientsJuly 27, 2017Lymphoma & Plasma Cell Disorders
FLT3-L level may point to relapsed/refractory multiple myelomaJuly 26, 2017Lymphoma & Plasma Cell Disorders
Avelumab induces response in Hodgkin lymphoma after failed allo-SCTJuly 20, 2017Lymphoma & Plasma Cell DisordersImmuno-oncology
IMiD/Anti-CD20 combo induces complete responses in r/r NHLJuly 19, 2017Lymphoma & Plasma Cell DisordersImmuno-oncologyFollicular Lymphoma
FDA okays ClearLLab test for hematologic cancer detectionJuly 11, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
Copanlisib makes inroads against relapsed/refractory follicular lymphomaJuly 11, 2017Lymphoma & Plasma Cell DisordersFollicular Lymphoma
R-CHOP matched more intense regimens for overall survival in high-risk, untreated DLBCLJuly 10, 2017Lymphoma & Plasma Cell Disorders
Tazemetostat active against follicular lymphoma with EZH2 mutationJuly 7, 2017Lymphoma & Plasma Cell DisordersFollicular Lymphoma
Ibrutinib/buparlisib looks good for relapsed mantle cell lymphomaJune 27, 2017Lymphoma & Plasma Cell DisordersFollicular Lymphoma
Pembrolizumab + rituximab boost response rates in relapsed follicular lymphomaJune 26, 2017ImmunotherapyLymphoma & Plasma Cell DisordersFollicular Lymphoma
CARs race for supremacy against aggressive non-Hodgkin lymphomaJune 25, 2017Lymphoma & Plasma Cell DisordersFollicular Lymphoma
Overall survival better in advanced Hodgkin lymphoma with shorter eBEACOPPJune 24, 2017Lymphoma & Plasma Cell Disorders
Twofer drug blocks SYK/JAK pathways in advanced NHLJune 23, 2017Lymphoma & Plasma Cell DisordersFollicular Lymphoma
